Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2007 Apr 1;175(7):737-42.
doi: 10.1164/rccm.200608-1088OC. Epub 2007 Jan 11.

Comparison of an interferon-gamma release assay with tuberculin skin testing in HIV-infected individuals

Annie F Luetkemeyer  1 , Edwin D Charlebois, Laura L Flores, David R Bangsberg, Steven G Deeks, Jeffrey N Martin, Diane V Havlir
Affiliations
Clinical Trial

Comparison of an interferon-gamma release assay with tuberculin skin testing in HIV-infected individuals

Annie F Luetkemeyer et al. Am J Respir Crit Care Med. .

Abstract

Rationale: Although interferon (IFN)-gamma release assays are approved for the diagnosis of latent tuberculosis infection (LTBI), limited data exist regarding their performance in HIV infection.

Objectives: To compare tuberculin skin test (TST) results to the commercial IFN-gamma release assay QuantiFERON-TB Gold In-Tube (QFT) for the diagnosis of LTBI in HIV-infected adults.

Methods: A total of 294 HIV-infected subjects sampled from two San Francisco cohorts underwent TST, using 5 TU of purified protein derivative, and QFT, measuring IFN-gamma response to Mycobacterium tuberculosis-specific RD-1 antigens.

Main results: Of 294 participants, 205 (70%) returned for an evaluable TST. Concordance between QFT and TST was 89.3% (kappa=0.37, p=0.007). However, in subjects with positive test results by either TST or QFT, only 28% (8/29) had positive test results by both modalities. TST-positive/QFT-negative discordant results were found in 5.1% of subjects and TST-negative/QFT-positive discordance in 5.6%. Indeterminate QFT results occurred in 5.1%, all due to a failure to respond to the phytohemagglutinin-positive control. Subjects with a CD4(+) count of less than 100 cells/mm(3) had a relative risk of an indeterminate result of 4.24 (95% confidence interval, 1.55-11.61; p=0.003) compared with those with a CD4(+) count of 100 or more.

Conclusions: Overall concordance between QFT and TST in HIV infection was high, but agreement among subjects with positive tests by either modality was low.

PubMed Disclaimer

Figures

<b>Figure 1.</b>
Figure 1.
Flow diagram for 294 HIV-infected subjects who underwent QuantiFERON-TB Gold In-Tube (QFT) and tuberculin skin testing (TST). Agreement, 89.3%; kappa = 0.37, p < 0.001.
See this image and copyright information in PMC

References

    1. World Health Organization. Two diseases: one patient. Report of the Third Global TB/HIV Working Group meeting. Geneva, Switzerland: World Health Organization; 2003.
    1. Lawn SD, Bekker LG, Wood R. How effectively does HAART restore immune responses to Mycobacterium tuberculosis? Implications for tuberculosis control. AIDS 2005;19:1113–1124. - PubMed
    1. Chaisson RE, Keruly JC, McAvinue S, Gallant JE, Moore RD. Effects of an incentive and education program on return rates for PPD test reading in patients with HIV infection. J Acquir Immune Defic Syndr Hum Retrovirol 1996;11:455–459. - PubMed
    1. Malotte CK, Rhodes F, Mais KE. Tuberculosis screening and compliance with return for skin test reading among active drug users. Am J Public Health 1998;88:792–796. - PMC - PubMed
    1. Caiaffa WT, Graham NM, Galai N, Rizzo RT, Nelson KE, Vlahov D. Instability of delayed-type hypersensitivity skin test anergy in human immunodeficiency virus infection. Arch Intern Med 1995;155:2111–2117. - PubMed

Publication types

Substances